Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and Thrombosis
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Hemostasis requires both platelets and the coagulation system. At sites of vessel injury, bleeding is minimized by the formation of a hemostatic plug consisting of platelets and fibrin. The traditional view of the regulation of blood coagulation is that the initiation phase is triggered by the extrinsic pathway, whereas amplification requires the intrinsic pathway. The extrinsic pathway consists of the transmembrane receptor tissue factor (TF) and plasma factor VII/VIIa (FVII/FVIIa), and the intrinsic pathway consists of plasma FXI, FIX, and FVIII. Under physiological conditions, TF is constitutively expressed by adventitial cells surrounding blood vessels and initiates clotting. In addition so-called blood-borne TF in the form of cell-derived microparticles (MPs) and TF expression within platelets suggests that TF may play a role in the amplification phase of the coagulation cascade. Under pathologic conditions, TF is expressed by monocytes, neutrophils, endothelial cells, and platelets, which results in an elevation of the levels of circulating TF-positive MPs. TF expression within the vasculature likely contributes to thrombosis in a variety of diseases. Understanding how the extrinsic pathway of blood coagulation contributes to hemostasis and thrombosis may lead to the development of safe and effective hemostatic agents and antithrombotic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Drake, T. A., Morrissey, J. H., & Edgington, T. S. (1989) · Europe PMC (PubMed Central) · Cited by 1,192
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042991 · Cited by 1,167
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A. (2007) · Stroke · doi:10.1161/01.str.0000254499.46122.22 · Cited by 1,034
del Conde, I., Shrimpton, C. N., Thiagarajan, P., & López, J. A. (2005) · Blood · doi:10.1182/blood-2004-03-1095 · Cited by 1,029
Role of tissue factor in embryonic blood vessel development
Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, L., Demunck, H., Kasper, M., Breier, G., Evrard, P., et al. (1996) · Nature · doi:10.1038/383073a0 · Cited by 669
Self-citationCellular origin and procoagulant properties of microparticles in meningococcal sepsis
Nieuwland, R., Berckmans, R. J., McGregor, S., Böing, A. N., Th. M. Romijn, F. P. H., Westendorp, R. G. J., Hack, C. E., & Sturk, A. (2000) · Blood · doi:10.1182/blood.v95.3.930.003k46_930_935 · Cited by 574
Yu, J. L., May, L., Lhotak, V., Shahrzad, S., Shirasawa, S., Weitz, J. I., Coomber, B. L., Mackman, N., & Rak, J. W. (2005) · Blood · doi:10.1182/blood-2004-05-2042 · Cited by 570
Self-citationContrino, J., Hair, G., Kreutzer, D. L., & Rickles, F. R. (1996) · Nature Medicine · doi:10.1038/nm0296-209 · Cited by 539
Shet, A. S., Aras, O., Gupta, K., Hass, M. J., Rausch, D. J., Saba, N., Koopmeiners, L., Key, N. S., & Hebbel, R. P. (2003) · Blood · doi:10.1182/blood-2003-03-0693 · Cited by 539
Self-citation
Cited by
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
Overview of the coagulation system
Palta, S., Saroa, R., & Palta, A. (2014) · Indian Journal of Anaesthesia · doi:10.4103/0019-5049.144643 · Cited by 901
Microparticles in Hemostasis and Thrombosis
Owens, A. P., & Mackman, N. (2011) · Circulation Research · doi:10.1161/circresaha.110.233056 · Cited by 835
Self-citationTissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Grover, S. P., & Mackman, N. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309846 · Cited by 667
Self-citationJackson, S. P., Darbousset, R., & Schoenwaelder, S. M. (2019) · Blood · doi:10.1182/blood-2018-11-882993 · Cited by 616
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Basílio, J., Petzelbauer, P., Assinger, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00085 · Cited by 596
Cross Talk Pathways Between Coagulation and Inflammation
Foley, J. H., & Conway, E. M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306853 · Cited by 589
Endothelium—role in regulation of coagulation and inflammation
van Hinsbergh, V. W. M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0285-5 · Cited by 588
The Hemostatic System as a Modulator of Atherosclerosis
Borissoff, J. I., Spronk, H. M. H., & ten Cate, H. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011670 · Cited by 569
Cellular Mechanisms Underlying the Formation of Circulating Microparticles
Morel, O., Jesel, L., Freyssinet, J.-M., & Toti, F. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.200956 · Cited by 526
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
Steffel, J., Lüscher, T. F., & Tanner, F. C. (2006) · Circulation · doi:10.1161/circulationaha.105.567297 · Cited by 456
Diesendruck, C. E., Sottos, N. R., Moore, J. S., & White, S. R. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500484 · Cited by 455
New insights into the mechanisms of venous thrombosis
Mackman, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60229 · Cited by 436
Self-citationStakos, D. A., Kambas, K., Konstantinidis, T., Mitroulis, I., Apostolidou, E., Arelaki, S., Tsironidou, V., Giatromanolaki, A., Skendros, P., Konstantinides, S., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv007 · Cited by 425
Role of Tissue Factor in Cancer
Kasthuri, R. S., Taubman, M. B., & Mackman, N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6324 · Cited by 412
Self-citationWolberg, A. S., Rosendaal, F. R., Weitz, J. I., Jaffer, I. H., Agnelli, G., Baglin, T., & Mackman, N. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.6 · Cited by 369
Self-citationThrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients
Claushuis, T. A. M., van Vught, L. A., Scicluna, B. P., Wiewel, M. A., Klein Klouwenberg, P. M. C., Hoogendijk, A. J., Ong, D. S. Y., Cremer, O. L., Horn, J., Franitza, M., et al. (2016) · Blood · doi:10.1182/blood-2015-11-680744 · Cited by 353
Tumor-derived tissue factor–positive microparticles and venous thrombosis in cancer patients
Geddings, J. E., & Mackman, N. (2013) · Blood · doi:10.1182/blood-2013-04-460139 · Cited by 336
Self-citationReinhardt, C., von Brühl, M.-L., Manukyan, D., Grahl, L., Lorenz, M., Altmann, B., Dlugai, S., Hess, S., Konrad, I., Orschiedt, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32376 · Cited by 323
Self-citationRole of reactive oxygen and nitrogen species in the vascular responses to inflammation
Kvietys, P. R., & Granger, D. N. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.002 · Cited by 312
Hemostatic strategies for traumatic and surgical bleeding
Behrens, A. M., Sikorski, M. J., & Kofinas, P. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35052 · Cited by 300
Engineered Hemostatic Biomaterials for Sealing Wounds
Montazerian, H., Davoodi, E., Baidya, A., Baghdasarian, S., Sarikhani, E., Meyer, C. E., Haghniaz, R., Badv, M., Annabi, N., Khademhosseini, A., et al. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01015 · Cited by 291
Qiao, Z., Lv, X., He, S., Bai, S., Liu, X., Hou, L., He, J., Tong, D., Ruan, R., Zhang, J., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.039 · Cited by 270
Breij, E. C. W., de Goeij, B. E. C. G., Verploegen, S., Schuurhuis, D. H., Amirkhosravi, A., Francis, J., Miller, V. B., Houtkamp, M., Bleeker, W. K., Satijn, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2440 · Cited by 227
Emerging materials for hemostasis
Li, X.-F., Lu, P., Jia, H.-R., Li, G., Zhu, B., Wang, X., & Wu, F.-G. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214823 · Cited by 164
Tissue factor expression in blood cells.
Østerud, B. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.032 · Cited by 111
Endothelial activation in lacunar stroke subtypes
Knottnerus, I. L. H., Govers-Riemslag, J. W. P., Hamulyak, K., Rouhl, R. P. W., Staals, J., Spronk, H. M. H., van Oerle, R., van Raak, E. P. M., Lodder, J., ten Cate, H., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.576223 · Cited by 75
Qiao, L., Chen, X., Xi, X., Chen, X., Zhang, P., Dong, H., Wu, X., & Chen, X. (2020) · Medicine · doi:10.1097/md.0000000000023329 · Cited by 22
The evolving landscape of antibody-drug conjugates (ADCs) for treatment of prostate cancer
Lin, C., Hadfield, M. J., Santopietro, A., Lagos, G., Cheng, L., El-Deiry, W. S., Aggarwal, R., Mega, A., Hyams, E., & Carneiro, B. A. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01131-0 · Cited by 20
Saini, A., & Farnoud, A. (2025) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70127 · Cited by 7
Metadata
- Authors
- Mackman, N., Tilley, R. E., & Key, N. S.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2007-08
- Volume
- 27
- Issue
- 8
- Pages
- 1687-1693
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2138712613
- Cited by
- 725
- References
- 75
- FWCI
- 23.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.